Picture Demy-Colton BioFuture 2024 NYC Game Changers 650x100px
Document › Details

Exscientia plc. (11/21/23). "Press Release: Exscientia to Present at the 6th Annual Evercore ISI HealthCONx Conference". Oxford.

Organisations Organisation Exscientia plc (Nasdaq: EXAI)
  Group Exscientia (Group)
  Organisation 2 Evercore ISI
  Group Evercore (Group)
Products Product Evercore ISI HealthCONx Conference 2023 Miami
  Product 2 AI-based drug discovery / AI-based drug development
Index term Index term Exscientia–Evercore: investor conference, 202311 supply service Exscientia participates in Evercore ISI HealthCONx Conference 2023
Persons Person Sherman, Sara (Exscientia 202109 Investor Relations)
  Person 2 Stohlmann, Oliver (Exscientia 202306 Media Relations)

Exscientia plc (Nasdaq: EXAI) today announced that members of Exscientia management will participate in a fireside chat at the 6th Annual Evercore ISI HealthCONx Conference on Tuesday, November 28, 2023, at 3:25 p.m. EST (8:25 p.m. GMT).

A live webcast of the fireside chat will be available on the Company’s website, under the “Investors & Media” section at An archived replay of the webcast will be available for approximately 30 days following the presentation.

About Exscientia

Exscientia is an AI-driven precision medicine company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner. Exscientia developed the first-ever functional precision oncology platform to successfully guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules into the clinical setting. Our internal pipeline is focused on leveraging our precision medicine platform in oncology, while our partnered pipeline broadens our approach to other therapeutic areas. By pioneering a new approach to medicine creation, we believe the best ideas of science can rapidly become the best medicines for patients.

Visit us at or follow us on X/Twitter @exscientiaAI.

Investor Relations:
Sara Sherman

Oliver Stohlmann
Source: Exscientia plc

Record changed: 2024-01-20


Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x200px

More documents for Exscientia (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Demy-Colton BioFuture 2024 NYC Game Changers 650x300px

» top